BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 32739239)

  • 1. Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease.
    Borghi C; Agabiti-Rosei E; Johnson RJ; Kielstein JT; Lurbe E; Mancia G; Redon J; Stack AG; Tsioufis KP
    Eur J Intern Med; 2020 Oct; 80():1-11. PubMed ID: 32739239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving cardiovascular and renal outcomes in gout: what should we target?
    Richette P; Perez-Ruiz F; Doherty M; Jansen TL; Nuki G; Pascual E; Punzi L; So AK; Bardin T
    Nat Rev Rheumatol; 2014 Nov; 10(11):654-61. PubMed ID: 25136785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy].
    Eliseev MS; Novikova AM
    Ter Arkh; 2019 May; 91(5):120-128. PubMed ID: 32598686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular Disease in Gout and the Protective Effect of Treatments Including Urate-Lowering Therapy.
    Gupta MK; Singh JA
    Drugs; 2019 Apr; 79(5):531-541. PubMed ID: 30868398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F; Leoncini G; Pontremoli R
    Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension, its treatment, hyperuricaemia and gout.
    Gibson TJ
    Curr Opin Rheumatol; 2013 Mar; 25(2):217-22. PubMed ID: 23370375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and Cardiovascular Disease.
    Zhang S; Wang Y; Cheng J; Huangfu N; Zhao R; Xu Z; Zhang F; Zheng W; Zhang D
    Curr Pharm Des; 2019; 25(6):700-709. PubMed ID: 30961478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric Acid in Inflammation and the Pathogenesis of Atherosclerosis.
    Kimura Y; Tsukui D; Kono H
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?
    Shah A; Keenan RT
    Curr Rheumatol Rep; 2010 Apr; 12(2):118-24. PubMed ID: 20425020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gout and hyperuricaemia: modifiable cardiovascular risk factors?
    Burnier M
    Front Cardiovasc Med; 2023; 10():1190069. PubMed ID: 37304945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiology of uric acid and fructose.
    Rho YH; Zhu Y; Choi HK
    Semin Nephrol; 2011 Sep; 31(5):410-9. PubMed ID: 22000647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options.
    Bardin T; Richette P
    BMC Med; 2017 Jul; 15(1):123. PubMed ID: 28669352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of hyperuricaemia and gout.
    Masseoud D; Rott K; Liu-Bryan R; Agudelo C
    Curr Pharm Des; 2005; 11(32):4117-24. PubMed ID: 16375732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus.
    Davies MJ; Trujillo A; Vijapurkar U; Damaraju CV; Meininger G
    Diabetes Obes Metab; 2015 Apr; 17(4):426-9. PubMed ID: 25600248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uric acid and cardiovascular disease: A clinical review.
    Saito Y; Tanaka A; Node K; Kobayashi Y
    J Cardiol; 2021 Jul; 78(1):51-57. PubMed ID: 33388217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gout and Metabolic Syndrome: a Tangled Web.
    Thottam GE; Krasnokutsky S; Pillinger MH
    Curr Rheumatol Rep; 2017 Aug; 19(10):60. PubMed ID: 28844079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent insights into the pathogenesis of hyperuricaemia and gout.
    Riches PL; Wright AF; Ralston SH
    Hum Mol Genet; 2009 Oct; 18(R2):R177-84. PubMed ID: 19808794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of uric acid in the pathogenesis of human cardiovascular disease.
    Kanbay M; Segal M; Afsar B; Kang DH; Rodriguez-Iturbe B; Johnson RJ
    Heart; 2013 Jun; 99(11):759-66. PubMed ID: 23343689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gout as a systemic disease: systemic manifestations and comorbidities of hyperuricaemia].
    Glasnović M
    Reumatizam; 2012; 59(2):119-32. PubMed ID: 23745468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.